Related Experiment Videos
Summary
Serogroup B meningococci causing infections in the UK predominantly possess serotype 2 antigen. These specific strains were less common in asymptomatic carriers without meningococcal disease.
Area of Science:
- Microbiology
- Immunology
- Epidemiology
Background:
- Neisseria meningitidis (meningococcus) is a significant bacterial pathogen.
- Serogroup B meningococci are a major cause of bacterial meningitis and sepsis.
- Understanding meningococcal serotypes is crucial for disease surveillance and control.
Purpose of the Study:
- To serologically characterize strains of group B meningococci.
- To investigate the association between specific serotypes and clinical outcomes (sporadic vs. epidemic infections).
- To compare serotypes found in patients with those found in asymptomatic carriers.
Main Methods:
- Serological typing technique was employed.
- Meningococcal strains were isolated from various sources: clinical cases (sporadic and epidemic) and asymptomatic carriers.
- Antigenic characterization of group B meningococcal strains.
Main Results:
- The majority of group B meningococcal strains from clinical infections in the United Kingdom exhibited serotype 2 antigen.
- Serotype 2 strains were found to be relatively uncommon among carriers without a history of meningococcal disease.
- This suggests a potential link between serotype 2 and invasive disease.
Conclusions:
- Serotype 2 antigen is a predominant characteristic of group B meningococci causing clinical infections in the UK.
- The lower prevalence of serotype 2 in asymptomatic carriers suggests it may be more associated with disease-causing potential.
- Further research into the virulence factors of serotype 2 strains is warranted.